Better-than-expected profits lift NuVasive shares

By · July 28, 2010 · No comments
Spine · Tagged: , ,

NuVasive reported better-than-expected profit for the second quarter and executives boosted their predictions for full-year earnings as sales surged for the San Diego spine-surgery device maker.

The San Diego company earned $6.7 million, or 17 cents a share, up from $2.8 million, or 7 cents a share, in 2009. Revenue for the quarter was $119.6 million, up 35 percent from a year earlier.

Excluding special charges, the company earned 42 cents a share, well above the 29 cents a share forecast of analysts polled by Thomson Reuters.

NuVasive raised its full-year profit predictions to $1.50 to $1.64 a share from the previous $1.13 to $1.25 a share.

NuVasive shares rose $1.49, or 4.4 percent, to $35.55 in after-hours trading after the results were announced.

Posted By

Josh Sandberg has been recruiting specifically in the musculoskeletal industry for over 8 years. Throughout this time, he has been able to have a positive impact on his client’s businesses. With an educational background in Business Management, Josh is adept to discern which people will be the best fit for the company he is searching for by understanding how candidates will incorporate with the company’s culture and operational nuances. His experience as an executive in a start-up business has granted him the ability to understand what is takes to thrive in a hands–on environment, where desire and dedication are paramount for success.
←
→

© 2012 OrthoSpineNews